| 查看: 304 | 回复: 2 | |||
madai26银虫 (小有名气)
|
[交流]
【求助】有没有虫子帮我查一下fasidotril这个药在国外有没有上市？ 已有2人参与
|
|
因为我们单位没啥数据库，所以查不到。 fasidotril 法西多曲 ACE/NEP双向抑制剂 临床试验做到3期，但后来就没下文了，哪位好心的虫子帮个忙呢？帮我把它有没有上市，在哪上市的查一下？ |
回复此楼» 猜你喜欢
[学习资料分享] FAERS数据库的不良反应挖掘(频数法/贝叶斯法)
已经有1人回复
-
招收医学、基础医学类调剂研究生
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有179人回复
-
是否属于脾肾阳虚证
已经有0人回复
-
[求助] 流式死活染 & 单细胞门控设置被质疑，如何优化并解释？
已经有1人回复
-
蛋白稳定性实验与功能实验不一致
已经有11人回复
-
第4年了，马上40了，可能我与国基确实无缘吧。。。
已经有12人回复
-
2026年申博药学专业
已经有1人回复
nkbeholder
木虫 (正式写手)
- DRDEPI: 1
- 应助: 11 (小学生)
- 金币: 2945.1
- 散金: 4
- 红花: 5
- 帖子: 748
- 在线: 303.7小时
- 虫号: 202353
- 注册: 2006-03-01
- 性别: GG
- 专业: 药物化学
★ ★
madai26(金币+2):谢谢参与
warlen(金币+1):谢谢参与 2010-08-04 15:15:09
madai26(金币+2):谢谢参与
warlen(金币+1):谢谢参与 2010-08-04 15:15:09
|
这上面写到2期就中止了。 Originator Company: Bioprojet (France) Parent Company: Bioprojet Licensee: Eli Lilly Highest Phase: Discontinued II Development Status: Discontinued II, France, Congestive heart failure Discontinued II, France, Hypertension Discontinued Preclinical, France, Postmyocardial infarction Introduction: Fasidotril, the prodrug of its active metabolite fasidoprilat, is a mixed inhibitor of ACE and neutral endopeptidase. It was undergoing phase II development with Bioprojet in France for the treatment of congestive heart failure and hypertension. It was also in preclinical development for postmyocardial infarction. However, development appears to have been discontinued. In October 2001, Bioprojet and Eli Lilly announced a development and commercialisation collaboration. Under the terms of the agreement, Lilly received exclusive worldwide commercialisation rights excluding Japan and certain countries in Europe. Lilly was to continue to develop fasidotril through to registration, and was to manufacture the finished product; Bioprojet was to manufacture the bulk material. |
2楼2010-08-04 14:45:13
mrzouhao
木虫之王 (文坛精英)
- DRDEPI: 1
- 应助: 179 (高中生)
- 贵宾: 0.108
- 金币: 99904.9
- 散金: 11601
- 红花: 134
- 沙发: 22
- 帖子: 46580
- 在线: 4386.8小时
- 虫号: 201350
- 注册: 2006-02-28
- 专业: 药剂学
3楼2010-08-04 15:13:10